Iceland vs North Macedonia: Protecting minority investors (DB06-14 methodology) - Score
Iceland
63.33
in 2013
North Macedonia
63.33
in 2013
Iceland rank
34th
North Macedonia rank
34th
Protecting minority investors (DB06-14 methodology) - Score over time
- Iceland
- North Macedonia
How they compare
Iceland currently reports 63.33 against 63.33 in North Macedonia, a difference of 0.
The two have swapped places 1 time across 9 shared years of data; in 2005 it was Iceland ahead.
Iceland ranks 34th and North Macedonia ranks 34th of 190 countries.
Across the 2 decades both report, Iceland averaged higher in 1 and North Macedonia in 1.
Head to head by decade
| Decade | Iceland | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 53.33 | 46 | 7.33 | Iceland |
| 2010s | 57.5 | 58.33 | 0.8333 | North Macedonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher protecting minority investors (db06-14 methodology) - score, Iceland or North Macedonia?
- Iceland, at 63.33 against 63.33 in North Macedonia as of 2013.
- What is the difference in protecting minority investors (db06-14 methodology) - score between Iceland and North Macedonia?
- 0, with Iceland ahead.
- How many years of comparable data are there for Iceland and North Macedonia?
- 9 years are reported by both, from 2005 to 2013.
- How do Iceland and North Macedonia rank globally for protecting minority investors (db06-14 methodology) - score?
- Iceland ranks 34th and North Macedonia ranks 34th of 190 countries.
- Where does this data come from?
- The World Bank, published as Protecting minority investors (DB06-14 methodology) - Score. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The score for protecting minority investors benchmarks economies with respect to the regulatory best practice on the indicator set. The score is indicated on a scale from 0 to 100, where 0 represents the worst regulatory performance and 100 the best regulatory performance, and is computed based on the methodology in the DB06-14 studies.